These EVPs are suggested to carry 2-Arachidonoylglycerol (2-AG) that binds to CB1, inhibiting GABA release and enhancing dopamine release to promote cocaine dependence (Covey et al., 2016; Nakamura et al., 2019). This evidence concerns the gene CNR1 and cocaine dependence.